Singh Dharmendra, Singh Pritanjali, Mandal Avik, Rakesh Amrita
Department of Radiotherapy, All India Institute of Medical Sciences, Deoghar, Jharkhand India.
Department of Radiotherapy, All India Institute of Medical Sciences, Patna, India.
Indian J Surg Oncol. 2024 May;15(Suppl 2):196-203. doi: 10.1007/s13193-024-01925-x. Epub 2024 Mar 18.
The aim of this study was to determine the 1- and 3-year overall survival rates. This prospective observational study was conducted at a tertiary care center in Bihar state, India. The study analyzed 228 patients in Bihar with a median age at diagnosis of 55 ± 12.05 years. The most common symptoms included upper abdominal pain (26.3%), weight loss (14%), and ascites (13.6%). The majority of patients presented at stage IV (72.8%), with liver metastasis being prevalent (61.4%). Interventional biliary drainage was performed in 9.6% of cases, and systemic chemotherapy was received by 84.64%, while 15.36% opted for best supportive care. Univariate Cox regression analysis identified Eastern Cooperative Oncology Group (ECOG) performance status, stage, gallstone disease, and surgical intervention as significant risk factors influencing overall survival (OS) ( < 0.001). Multivariate Cox regression analysis confirmed ECOG performance status ( < 0.001), stage ( = 0.039), and surgical intervention ( = 0.038) as independent factors impacting OS. One-year OS rates for stages II, III, and IV were 100%, 97%, and 44%, respectively, while 3-year OS rates were 29%, 4%, and 0%. Surgical intervention significantly influenced OS ( < 0.001). OS for surgical intervention was 28 months, and for inoperable cases, it was 12 months. One- and 3-year OS for surgical intervention were 95% and 11%, while for inoperable cases, they were 41% and 0%, respectively. Patients with gallbladder cancer, particularly in Bihar's Gangetic plains, face poor survival, especially with advanced disease. Adequate surgery improves outcomes, prompting a call for enhanced strategies, particularly for locally advanced GBC.
本研究的目的是确定1年和3年总生存率。这项前瞻性观察性研究在印度比哈尔邦的一家三级医疗中心进行。该研究分析了比哈尔邦的228例患者,诊断时的中位年龄为55±12.05岁。最常见的症状包括上腹部疼痛(26.3%)、体重减轻(14%)和腹水(13.6%)。大多数患者处于IV期(72.8%),肝转移很常见(61.4%)。9.6%的病例进行了介入性胆管引流,84.64%接受了全身化疗,而15.36%选择了最佳支持治疗。单因素Cox回归分析确定东部肿瘤协作组(ECOG)体能状态、分期、胆结石疾病和手术干预是影响总生存(OS)的显著危险因素(<0.001)。多因素Cox回归分析证实ECOG体能状态(<0.001)、分期(=0.039)和手术干预(=0.038)是影响OS的独立因素。II期、III期和IV期的1年总生存率分别为100%、97%和44%,而3年总生存率分别为29%、4%和0%。手术干预对OS有显著影响(<0.001)。手术干预组的OS为28个月,不可手术病例为12个月。手术干预组的1年和3年总生存率分别为95%和11%,而不可手术病例分别为41%和0%。胆囊癌患者,尤其是比哈尔邦恒河平原地区的患者,生存情况较差,尤其是疾病晚期。充分的手术可改善预后,因此需要加强策略,特别是针对局部晚期胆囊癌。